Cathy Sun
University of Ottawa
6 Papers
8 Citations
Cathy Sun is an academic researcher from University of Ottawa. The author has contributed to research in topics: Internal medicine & Dyslipidemia. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
Comparison of three methods for LDLC calculation for cardiovascular disease risk categorization in three distinct patient populations.
TL;DR: In this paper , the authors studied the correlation and discordance for stratification into the Canadian Cardiovascular Society (CCS) 2021 Dyslipidemia Guidelines' cardiovascular disease (CVD) risk categories.
4
Ginsenoside Variation Within and Between Ontario Ginseng Landraces: Relating Phytochemistry to Biological Activity
Kristina L. McIntyre,Alice Luu,Cathy Sun,Daniel C. W. Brown,Emk Lui,John T. Arnason +5 more
- 01 Jan 2011
TL;DR: Identifying variation in ginsenoside profiles and this effect on biological activity could be important for quality control and landrace development.
4
Thyroid-Stimulating Hormone-Stimulated Human Adipocytes Express Thymic Stromal Lymphopoietin.
Loretta Ma,AnneMarie Gagnon,Anne Landry,Timothea Le,Fengxia Xiao,Cathy Sun,Heather A. Lochnan,Heather A. Lochnan,Dylan Burger,Dylan Burger,Alexander Sorisky,Alexander Sorisky +11 more
TL;DR: TSLP is a novel TSH-responsive adipokine and future studies will be needed to address the potential role of adipocyte-derived TSLP and whether it is linked to T SH-dependent platelet activation.
2
A More Atherogenic Lipoprotein Status Is Present in Adults With Than Without Type 2 Diabetes Mellitus With Equivalent Degrees of Hypertriglyceridemia.
TL;DR: In this paper , the impact of type 2 diabetes (T2DM) on biomarkers denoting lipoprotein compositional status was studied in mild and moderate hypertriglyceridemia (HTG).
1
Improving Glycemic Control in Adults and Children With Type 1 Diabetes With the Use of Smartphone-Based Mobile Applications: A Systematic Review.
TL;DR: The need for larger and longer studies to explore the efficacy of apps to optimize outcomes in type 1 diabetes is highlighted, the populations that would benefit most from these tools and the resources needed to support mobile apps plus text-messaging/feedback systems are highlighted.